undamentalytics Newsletter

Loranger Steven R: insider trades

Director at 2 companies we cover. 1 open-market purchase and 14 sales not made under a pre-set plan, reported from February 13, 2012 to February 14, 2025.

Would copying Loranger Steven R’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 1 purchase has 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on May 27, 2016 into $14,711 by November 2, 2026, +3.8% a year. The copy held shares only 10% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $15,056, +4.0% a year (the S&P 500 held throughout made $42,567, +14.9% a year). Beta against the index was 0.03. Twelve months after each report, the average purchase was −2.7% against the S&P 500 (median −2.7%), and 0% beat it. Measured from the trade date, the insider’s own timing, the average was −5.6%. After their sales, the shares moved −1.0% against the index over 12 months on average (a negative figure means selling was the right call); 71% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$20.0k$40.0k 201620182020202220242026 $42.6k$15.1k$14.7k
Copying Loranger Steven RS&P 500, same days investedS&P 500, held throughout $10,000 copying Loranger Steven R’s open-market purchases from May 27, 2016, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
+3.8%
S&P 500, same days invested
+4.0% (held throughout +14.9%)
Time in shares
10%
Sharpe ratio (S&P 500)
0.18 (0.74)
Biggest drop (S&P 500)
−33% (−34%)
Market sensitivity (beta)
0.03
Purchases copied
1

Trade by trade

Loranger Steven R: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 1 +11.3% +11.3% 100% 1 — — Not enough years
Purchases, 6 months after the report 1 −20.7% −20.7% 0% 1 — — Not enough years
Purchases, 12 months after the report 1 −2.7% −2.7% 0% 1 — — Not enough years
Purchases, 12 months after the trade 1 −5.6% −5.6% 0% 1 — — Not enough years
Sales, 3 months after the report 14 +2.6% +5.4% 21% 8 1.15 0.29 No reliable evidence
Sales, 12 months after the report 14 −1.0% −4.6% 71% 8 0.42 0.69 No reliable evidence
Sales, 12 months after the trade 14 −1.6% −5.5% 71% 8 0.26 0.80 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Xylem Inc. XYL —013February 13, 2012September 15, 2020
Edwards Lifesciences EW —11May 26, 2016February 14, 2025

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
February 14, 2025February 14, 2025 EW Sale $438,574 +5.6%−9.0%−10.2%
September 15, 2020September 11, 2020 XYL Sale $1,543,673 +7.9%+23.6%+22.9%
February 14, 2020February 12, 2020 XYL Sale $2,658,300 −17.5%−5.4%−5.5%
March 18, 2019March 15, 2019 XYL Sale $769,900 +0.3%−1.7%−0.7%
November 8, 2017November 6, 2017 XYL Sale $2,497,625 +5.2%−1.3%−2.0%
June 2, 2016June 1, 2016 XYL Sale $2,226,000 +7.3%+0.1%+0.5%
May 31, 2016May 27, 2016 XYL Sale $2,233,500 +9.9%+0.5%+0.5%
May 26, 2016May 24, 2016 EW Purchase $505,350 +11.3%−2.7%−5.6%
November 6, 2015November 4, 2015 XYL Sale $6,078,568 +10.4%+32.1%+28.9%
November 13, 2014November 12, 2014 XYL Sale $3,751,000 −7.8%−3.9%−5.6%
September 18, 2012September 14, 2012 XYL Sale $1,840,035 +4.3%−13.3%−10.8%
September 14, 2012September 12, 2012 XYL Sale $1,216,194 +8.2%−10.0%−10.1%
September 11, 2012September 7, 2012 XYL Sale $3,042,580 +7.9%−10.1%−10.2%
March 7, 2012February 9, 2012 XYL Sale $2,605,865 +0.3%−7.2%−10.1%
February 13, 2012February 9, 2012 XYL Sale $2,709,000 −5.1%−7.8%−10.1%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Loranger Steven R traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.